N,N-DIISOPROPYL-2-METHOXY-4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)BENZAMIDE, 95%, 100mg

Objetivo de indio 99,99% dia. 101,6 mm x espesor 3,18 mm 1 ud.

(2-(4-(Methoxycarbonyl)piperidin-1-yl)pyrimidin-5-yl)boronic acid, 95.0%, 100mg

BENDAZAC L-LYSINE, 95%, 5g

N-(2,4-Dinitrophenyl)-L-valine>98.0%(HPLC)(T)100mg

(R)-2-Amino-2-(2-chlorophenyl)acetic acid hydrochloride, 97%, 2.5g

4-(Azetidin-1-yl)benzoic acid, 95.0%, 100mg

4-CHLORO-3-METHYL-1H-PYRAZOLO[4,3-C]PYRIDINE, 95.0%, 250mg

4-Chloro-1H-pyrrolo[3,2-c]pyridine-3-carbonitrile, 97%, 1g

Methyl 2-amino-6-fluoro-3-nitrobenzoate, 98.0%, 10g

4-(4-Bromo-phenyl)-3-sulfamoyl-5-trifluoromethyl-thiophene-2-carboxylic acid methyl ester, 95.0%, 1g

3-Phenoxypropan-1-amine hydrochloride, 95.0%, 5g

Methyl 6-oxospiro[3.3]heptane-2-carboxylate, 95.0%, 5g